37541 |
Oncology |
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Pa... |
J CLIN ONCOL 2020 10.1200/JCO.19.01834 |
이지연 |
2020 |
37540 |
Pharmacology & Pharmacy |
Phase I clinical trial of KML001 monotherapy in patients with advanced... |
EXPERT OPIN INV DRUG 2020 10.1080/13543784.2020.1804855 |
이지연 |
2020 |
37539 |
Oncology; Immunology |
Incorporating sarcopenia and inflammation with radiation therapy in pa... |
CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02794-3 |
이지연 |
2020 |
37538 |
Immunology |
IL-7R alpha(low) CD8(+) T Cells from Healthy Individuals Are Anergic w... |
J IMMUNOL 2020 10.4049/jimmunol.1901470 |
이지연 |
2020 |
37537 |
Oncology |
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherap... |
JAMA ONCOL 2020 10.1001/jamaoncol.2020.3370 |
이지연 |
2020 |
37536 |
Oncology; Radiology, Nuclear Medicine & Medical Imaging |
Effect of baseline sarcopenia on adjuvant treatment for D2 dissected g... |
RADIOTHER ONCOL 2020 10.1016/j.radonc.2020.07.043 |
이지연 |
2020 |
37535 |
Oncology |
Clinical and molecular distinctions in patients with refractory colon ... |
THER ADV MED ONCOL 2020 10.1177/1758835920965842 |
이지연 |
2020 |
37534 |
Oncology |
A Multi-cohort Study of the Prognostic Significance of Microsatellite ... |
CANCER RES TREAT 2020 10.4143/crt.2020.173 |
이지연 |
2020 |
37533 |
Urology & Nephrology |
Docetaxel rechallenge in metastatic castration-resistant prostate canc... |
INVESTIG CLIN UROL 2020 10.4111/icu.20200214 |
박세훈 |
2020 |
37532 |
Oncology |
A Phase II Trial of Tipifarnib for Patients with Previously Treated, M... |
CLIN CANCER RES 2020 10.1158/1078-0432.CCR-20-1246 |
박세훈 |
2020 |